|
Gastroenterology / Original Article
Live zoster vaccination and hepatobiliary risk reduction: a nationwide South Korean study
Junyeol Kim, Kyeongmin Lee, Jiyeon Oh, Hayeon Lee, Jong-In Chang, Tae Young Park, Dong Keon Yon, Hyoung-Chul Oh
Korean J Intern Med. 2025;40(5):747-758. Published online August 29, 2025
Background/Aims: Herpes zoster (HZ) vaccination is primarily administered to prevent shingles, yet its systemic immunomodulatory effects may offer protection against other organ-related diseases, including hepatobiliary and pancreatic diseases. Therefore, this emulated target trial aimed to evaluate..
|
|
|
Gastroenterology / Review
Herpes zoster infection in patients with inflammatory bowel disease
Dong Hyun Kim, Sang-Bum Kang
Korean J Intern Med. 2025;40(3):347-356. Published online April 30, 2025
Patients with inflammatory bowel disease (IBD) are at increased risk of herpes zoster (HZ), particularly those receiving immunosuppressive treatments such as corticosteroids, thiopurines, and biologics, which elevate the likelihood of varicella-zoster virus reactivation. Despite this, vaccination ra..
|
|
|
Infectious diseases / Original Article
Mediation effect of herpes zoster derived by statin use on cardiovascular disease risk
Sung-Han Kim, Sung-Cheol Yun, Young-Ho Khang, Min-Chul Kim, Sun Uck Kwon, Gyung-Min Park, Young-Rak Cho, Kwang Min Lee, Moo Hyun Kim
Korean J Intern Med. 2020;35(5):1220-1228. Published online June 19, 2020
Background/Aims: Although statins are widely used to reduce the risk of cardiovascular disease (CVD) including stroke and myocardial infarction (MI), it is reported that statin use increases the incidence of herpes zoster (HZ) that is associated with increased risk of CVD. So, we evaluated the media..
|
|
|
